• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

GSK’s new T1 drug fails phase III clinical trial

30/03/2011 No Comments

GlaxoSmithKline says that Otelixizumab, a Type 1 drug currently under development, has failed in a phase III clinical trial. The drug has been in development

Read More ยป

Follow us elsewhere

Facebook
Twitter
Instagram

Latest tweets

Twitter: desangsue
Sue Marshall
  • Cities Changing Diabetes - https://t.co/YeMhZfi4Nr 09:06:53 AM February 24, 2021
@desangsue

Recent posts

Cities Changing Diabetes

Terumo insulin pump

California backs CGM

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill